This article is part of the supplement: B cells in autoimmune diseases: Part 2
B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design
Arthritis Research & Therapy 2013, 15(Suppl 1):S2 doi:10.1186/ar3910
No comments have yet been made on this article.
